Navigation Links
Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
Date:7/6/2008

with the control arm (30 percent versus 5 percent, (p <0.001)), and grade 3 neuropathy occurred in 4 percent of the OPAXIO patients, with no occurrences of grade 4 neuropathy. There was a lower incidence of alopecia in the OPAXIO arm (2 percent versus 5 percent respectively, p = 0.085), as well as fatigue (16 percent versus 25 percent, p= 0.055), asthenia (11 percent versus 16 percent, p = 0.169), and weight loss (7 percent versus 12 percent, p = 0.121).

Details of the Study

The phase III trial, reported by Mary E. R. O'Brien, M.D., F.R.C.P., et al, of the Royal Marsden Hospital and the Kent Cancer Centre in Surrey, UK, was a randomized, multi-center trial. The trial was conducted at 83 centers in ten countries, and randomized on a 1:1 ratio to evaluate the efficacy and safety of this regimen in patients with chemotherapy-nave NSCLC. Patients with advanced stage IIIb/IV NSCLC and PS 2 were treated with OPAXIO on day 1 of a 21-day cycle, while patients receiving gemcitabine were treated on days 1, 8, and 15 of each 28-day cycle. Vinorelbine was administered on days 1, 8, and 15 of each 21-day cycle. Patients received up to six cycles of treatment, and were not treated until significant toxicities were under control (less than or equal to grade 1). The primary objective was effect on survival, and secondary objectives were determining the efficacy and safety of the treatments.

About OPAXIO(TM)

OPAXIO(TM) (paclitaxel poliglumex, CT-2103), which was previously branded as XYOTAX(TM), is an investigational, biologically enhanced, chemotherapeutic that links paclitaxel, the active ingredient in Taxol(R), to a biodegradable polyglutamate polymer, which results in a new chemical entity. When bound to the polymer, paclitaxel is rendered inactive, potentially sparing normal tissue's exposure to high levels of the active drug and its associated toxicities. Blood vessels in tumor tissue, unlike blood vessels in normal tissue, are porous to molecules l
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
2. Genzyme and Isis Complete Licensing of Mipomersen
3. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
4. Metabolex Completes Patient Enrollment in Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
5. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
6. Pharmaxis Long-Term Safety Study of Bronchitol Completes
7. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
8. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
9. Phase 1/2 Trial of Motexafin Gadolinium Plus Antibody Targeted Radiation Therapy Demonstrates High Complete Response Rate in Patients With Non-Hodgkins Lymphoma
10. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
11. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 The American Association for ... Maryland , announced today the filing of ... Washington, D.C. , asking that the scheduled July ... durable medical equipment (DME) be stopped because of serious licensing ... and Human Services (HHS) Secretary Kathleen Sebelius ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... a new market research report is ... Partnerships, Licensing, Investments and M&A ... in Pharmaceuticals http://www.reportlinker.com/p0925641/Partnerships-Licensing-Investments-and-MA-Deals-and-Trends-for-May-2013-in-Pharmaceuticals.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Investment_Banking ... and M&A Deals and Trends for ...
(Date:6/19/2013)... , June 19, 2013   NextDocs ... full service clinical research organization, at DIA 2013 ... The companies will present case studies that explore best ... file to electronic trial master file (eTMF) systems. ... NextDocs will present alongside Krystyna Kowalczyk , executive ...
Breaking Medicine Technology:AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 2AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 3AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 4AAHomecare and Maryland DME Provider Take Medicare Agency to Court Over Competitive Bidding Program 5Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 2Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 3Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 4Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 5Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 6Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 7Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 8Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 9Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 10Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 11Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 12Partnerships, Licensing, Investments and M&A Deals and Trends for May 2013 in Pharmaceuticals 13NextDocs and Novella to Present on eTMF at DIA 2013 2
(Date:6/20/2013)... 20, 2013 TASC, a national ... a new service to deal with funding the ... Patient Protection & Affordable Care Act (PPACA), the ... outcomes, clinical effectiveness, and appropriateness" of different medical ... conduct its own, with funding in part by ...
(Date:6/20/2013)... In an article found on Science Daily's ... similarities between an addiction to drugs, and an addiction ... obesity pandemic. , To test the hypothesis that one ... be addicted to drugs, Dr Francesco Leri, Associate Professor ... of Guelph, has studied the effects of food containing ...
(Date:6/20/2013)... KS (PRWEB) June 20, 2013 The ... launch of its new, online Master of Science ... Essentials of Master’s Education in Nursing from the American ... eventually become the foundation of most major nursing master’s ... in Nursing program from the University of Saint Mary ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Brand new Hypertrophy Max ... the 4 day sale on the Hypertrophy Max program. Vince ... 24 hours so those that are interested must act quickly. , ... new Hypertrophy Max bonus is a free 12 month all access ... , According to Ryan Davids "Live Large TV is a Monday ...
(Date:6/19/2013)... (PRWEB) June 20, 2013 A man returning from ... he used to be. In his debut book titled RED DANCER ... veteran who immerses himself back home, looking for the right place ... De Los Angeles, former marine from the Vietnam War, returns to ... the edge off his PTSD. Wings, a wealthy acquaintance from a ...
Breaking Medicine News(10 mins):Health News:TASC Service Helps Employers Handle New Burdens for Health Reimbursement Arrangement Plans 2Health News:Research Suggests That Unhealthy Food Addiction Could Explain Global Obesity Epidemic 2Health News:University of Saint Mary Launches New Online Master of Science in Nursing Built on the Latest AACN Essentials 2Health News:University of Saint Mary Launches New Online Master of Science in Nursing Built on the Latest AACN Essentials 3Health News:New Hypertrophy Max Bonus Just Released and Only Available for 24 Hours 2Health News:Rafael Fragauda’s New Book Underlines Post Traumatic Stress Disorder 2
... ... Business in Northern California, was started with a vision of helping customers achieve a ... by an educational strategy to help promote health and wellness for customers, and their ... BVibrantNow is doing it!, , ...
... ... walking boots for individuals with very small or very large feet and legs. ... medical facility inventories, and Orthotics And Beyond has expanded its cam boot walker line ... , ...
... ... will begin a long trek to the summit of Mount Kilimanjaro in Tanzania on July ... , ... -- A Chicago father and son team will begin a long trek to the summit ...
... News) -- One way to have a safe July ... experts, a children,s eye specialist advises. "Fireworks exhibits ... should not play with these devices that can cause ... pediatric ophthalmologist at the Indiana University School of Medicine ...
... ... parents feel that their child has a healthy diet, particularly those from wealthier families. Yet, ... fresh ingredients or cutting out snacks, junk food and takeaways. , ... (PRWEB) July 4, 2010 -- According to a ...
... Estetique, Inc., ... aesthetic machines. The new equipment will be distributed to medical spas, plastic surgeons and ... machines and equipment. , ... Miramar, FL (PRWEB) July 4, 2010 -- Estetique, a leader in medical spa and ...
Cached Medicine News:Health News:BVibrantNow, A New All-Natural Health Supplement Business, Launches Free Online Wellness Calendar to Promote Healthy Habits 2Health News:BVibrantNow, A New All-Natural Health Supplement Business, Launches Free Online Wellness Calendar to Promote Healthy Habits 3Health News:Extended Sizes and Accessories for Medical Walking Boots are Now Available from Orthotics And Beyond 2Health News:Chicago Father and Son Team to Climb Mount Kilimanjaro for ShelterBox 2Health News:Chicago Father and Son Team to Climb Mount Kilimanjaro for ShelterBox 3Health News:Leave July 4 Fireworks to the Pros 2Health News:Parents Overestimate Children's Diets as Healthy 2Health News:Parents Overestimate Children's Diets as Healthy 3Health News:Parents Overestimate Children's Diets as Healthy 4Health News:Estetique Launches New Line of IPL Aesthetic Equipment 2
... is the aqueous ... It is a fast-acting, ... gram-positive and gram-negative bacteria ... as well as most ...
... the one-step prep solution, allows the user ... applies and dries in less than 2-minutes. ... commonly used in surgical scrubbing and healthcare ... added to help provide a tacky surface ...
... designed for individual application and are ideal ... nursing homes, home healthcare settings, blood banks, ... departments. This unit dose pouch contains hydrogen ... and cleansing agent. Hydrogen Peroxide's chief value ...
... This multi-purpose topical solution ... Povidone Iodine Prep Spray is ... the possibility of cross contamination. ... an alternate method to the ...
Medicine Products: